ANI Pharmaceuticals | ANIP - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -6.66B 3.39B 2026-03
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Canopy Growth CAD 758.17M 22.16M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Heron Therapeutics USD 9.14M 4.15M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 46.13B 1.8B 2025-12
Omeros USD -228.68M 15.13M 2025-06
Perrigo USD 2.5B 436.7M 2026-03
Sun Pharmaceuticals INR 835.7B 57.5B 2026-03
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03